Evidence map›Paper›PMID 28848880›Full record

ArticleChronic obstructive pulmonary diseases (Miami, Fla.)2016

Free Urinary Desmosine and Isodesmosine as COPD Biomarkers: The Relevance of Confounding Factors.

Sara Ongay, Marijke Sikma, Peter Horvatovich, Jos Hermans, Bruce E Miller, Nick H T Ten Hacken, Rainer Bischoff

Open access · diamondAbstract read
In one paragraph

Article in Chronic obstructive pulmonary diseases (Miami, Fla.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.3field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Sara OngayUniversity of Groningen, Department of Pharmacy, Analytical Biochemistry, Groningen, The Netherlands.
Marijke SikmaUniversity of Groningen, Department of Pharmacy, Analytical Biochemistry, Groningen, The Netherlands.
Peter HorvatovichVan Hall Larenstein Hogeschool, Leeuwarden, Agora, The Netherlands.
Jos HermansUniversity of Groningen, Department of Pharmacy, Analytical Biochemistry, Groningen, The Netherlands.
Bruce E MillerGlaxoSmithKline Research and Development, King of Prussia, Pennsylvania.
Nick H T Ten HackenUniversity of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
Rainer BischoffUniversity of Groningen, Department of Pharmacy, Analytical Biochemistry, Groningen, The Netherlands.
University of Groningen · NLVan Hall Larenstein University of Applied Sciences · NLGlaxoSmithKline (United States) · USUniversity Medical Center Groningen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkerCOPDdesmosineECLIPSEisodesmosineurine

Identifiers

PMID28848880
PMCPMC5559158
OpenAlexW2580570851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.